| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 25.436 | 27.253 | 26.929 | 27.789 | 26.638 | 29.908 | 37.969 | 40.877 | 40.545 |
| Total Income - EUR | - | 25.436 | 27.253 | 26.929 | 27.789 | 26.638 | 29.908 | 37.969 | 40.877 | 40.545 |
| Total Expenses - EUR | - | 16.386 | 26.714 | 31.540 | 37.662 | 29.201 | 46.734 | 32.751 | 22.358 | 38.187 |
| Gross Profit/Loss - EUR | - | 9.050 | 539 | -4.611 | -9.872 | -2.563 | -16.826 | 5.217 | 18.519 | 2.358 |
| Net Profit/Loss - EUR | - | 8.796 | 267 | -4.880 | -10.150 | -2.829 | -17.125 | 4.838 | 18.111 | 1.960 |
| Employees | - | 1 | 0 | 0 | 3 | 2 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Denoptic-Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 13.684 | 21.231 | 12.867 | 10.850 | 2.536 | 3.419 | 3.937 | 12.792 | 13.457 |
| Inventories | - | 12.466 | 20.437 | 12.765 | 10.619 | 2.042 | 507 | 1.097 | 7.779 | 12.509 |
| Receivables | - | 0 | 390 | 0 | 0 | 176 | 2.060 | 2.239 | 2.495 | 121 |
| Cash | - | 1.219 | 404 | 102 | 231 | 318 | 852 | 601 | 2.518 | 827 |
| Shareholders Funds | - | 8.841 | 8.958 | 3.913 | -9.282 | -11.935 | -28.795 | -24.047 | -5.864 | -3.870 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 4.844 | 12.273 | 8.954 | 20.132 | 14.471 | 32.215 | 27.984 | 18.656 | 17.327 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Denoptic-Medical Srl